The International Journal of Tuberculosis and Lung Disease

Measuring tuberculosis: lessons from Afghanistan [Editorial]
pp. 1041-1042(2)
Author: Donald A. Enarson

Quality and stability of TB medicines: let the buyer beware! [Editorial]
pp. 1043-1044(2)
Authors: Richard Laing; Hugo Vrakking; Bernard Fourie

Lung cancer epidemiology and risk factors in Asia and Africa [State of the Art]
pp. 1045-1057(13)
Authors: W.K. Lam; N.W. White; M.M. Chan-Yeung

Implementing joint TB and HIV interventions in a rural district of Malawi: is there a role for an international non-governmental organisation? [Unresolved Issues]
pp. 1058-1064(7)
Authors: R. Zachariah; R. Teck; A.D. Harries; P. Humblet

A tuberculin skin test survey among Afghan children in Kabul
pp. 1065-1072(8)
Authors: M. Dubuis; K. Fiekert; M. Johnston; B.E. Neuenschwander; H.L. Rieder

The physical and chemical stability of anti-tuberculosis fixed-dose combination products under accelerated climatic conditions
pp. 1073-1080(8)
Authors: H. Bhutani; T.T. Mariappan; S. Singh

Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study
pp. 1081-1088(8)
Authors: Y. Ashokraj; S. Agrawal; M.V.S. Varma; I. Singh; K. Gunjan; K.J. Kaur; S.R. Bhade; C.L. Kaul; J.M. Caudron; J. Pinel; R. Panchagnula

Auditing the new decentralised oral treatment regimens in Malawi
pp. 1089-1094(6)
Authors: T.E. Nyirenda; A.D. Harries; F.K. Gausi; K. Ito; J.R. Kemp; B.S. Squire; P. Godfrey-Faussett; F.M. Salaniponi

Design and implementation of relational databases relevant to the diverse needs of a tuberculosis case contact study in The Gambia
pp. 1095-1099(5)
Authors: D.J. Jeffries; S. Donkor; R.H. Brookes; A. Fox; P.C. Hill

The assessment of patients' health-related quality of life during tuberculosis treatment in Wuhan, China
pp. 1100-1106(7)
Author: D. Chamla

The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany
pp. 1107-1113(7)
Authors: T. Kubica; S. Rüsch-Gerdes; S. Niemann

Simple, phage-based (FASTPlaque) technology to determine rifampicin resistance of Mycobacterium tuberculosis directly from sputum
pp. 1114-1119(6)
Authors: H. Albert; A. Trollip; T. Seaman; R.J. Mole

Right heart dysfunction in post-tuberculosis emphysema
pp. 1120-1126(7)
Authors: M.A. Kim; S.H. Kim; J.H. Zo; B. Hwangbo; J.H. Lee; H.S. Chung

Social research as an intervention tool in tuberculosis control
pp. 1127-1129(3)
Authors: H.C.J. van Rensburg; H. Meulemans; L. Rigouts; J.C. Heunis; E. Janse van Rensburg; S.Z. Matebesi; A. Van der Spoel; C. Timmerman; D. De Graeve; L. Pauwels; F. Portaels; B. Gryseels; J. van Houtte

Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy ‘normals’
pp. 1130-1133(4)
Authors: G. Ramachandran; T. Santha; R. Garg; D. Baskaran; S.A. Iliayas; P. Venkatesan; R. Fathima; P.R. Narayanan

Local production of nitric oxide in patients with tuberculosis
pp. 1134-1137(4)
Authors: T. Schön; G. Elmberger; Y. Negesse; R. Hernandez Pando; T. Sundqvist; S. Britton

The oxygen concentrator: an appropriate technology for treating hypoxaemic children in developing countries
pp. 1138-1141(4)
Authors: A. Perrelet; J-P. Zellweger; I. Talla; Y. Ndiaye; E. Gautier; M. Gehri

Identification of a familial cluster of pulmonary Mycobacterium bovis disease [Case Study]
pp. 1142-1146(5)
Authors: P.A. LoBue; W. Betancourt; L. Cowan; L. Seli; C. Peter; K.S. Moser

Polymerase chain reaction based detection of Mycobacterium tuberculosis complex in lupus vulgaris: a case report [Case Study]
pp. 1147-1150(4)
Authors: O. Baylan; E. Arca; A. Ozcan; O. Kisa; A. Albay; L. Doganci

Choosing a research study design and selecting a population to study [Research Methods]
pp. 1151-1156(6)
Authors: D.A. Enarson; S.M. Kennedy; D.L. Miller

Correspondence
pp. 1157-1158(2)